Mechanisms of reduced regenerative potential in aging skeletal muscle

衰老骨骼肌再生潜力降低的机制

基本信息

  • 批准号:
    8443387
  • 负责人:
  • 金额:
    $ 6.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-01 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): As we age, the regenerative capacity of skeletal muscle declines, prolonging or preventing complete recovery and rehabilitation from muscle injury. In fact older adults often never recover muscle mass and strength following an injury; leading to fatigue, activity limitations, and ultimately a loss of independence. Background: Effective recovery of injured skeletal muscle is driven by activation of resident satellite cells. Concurrently, the inflammatory response clears cellular debris and promotes satellite cell differentiation. However, the inflammatory process can also delay recovery by damaging cellular components via oxidative stress. Satellite cells retain their regenerative potential throughout lif, if exposed to the proper environment. Therefore, dietary supplements designed to augment satellite cell activity and minimize oxidative stress have the potential to improve skeletal muscle rehabilitation following acute injury. Hypotheses and Approach: L-arginine can act as an antioxidant, as well as a stimulator of satellite cell activation in cell culture. Therefore, we propose a novel application of dietary L-arginine therapy to simultaneously augment satellite cell activity and inhibit inflammatory stress in vivo. This project will translate our preliminary cell culture data into an in vivo animal model and explore the mechanisms underlying the functional effects of L- arginine in adult skeletal muscle. We hypothesize that L-arginine supplementation following acute myotoxin injury will augment recovery of muscle mass by inhibiting activation of the inflammatory mediator, NF-kB, and enhancing activation of resident satellite cells. Further, that these effects will be dependent upon nitric oxide production. Significance: Physical rehabilitation following muscular injury is a major health care expense. More importantly, the loss of muscle mass with aging coupled with the failure to fully recover muscle following injury leads to physical frailty and increased risk of metabolic disease. Therefore, this project seeks to improve our mechanistic understanding of muscle regeneration and translate basic science data into effective dietary supplement strategies to augment muscle injury recovery. and contractile function in aging mice
描述(由申请人提供):随着年龄的增长,骨骼肌的再生能力下降,延长或阻止肌肉损伤的完全恢复和康复。事实上,老年人在受伤后往往无法恢复肌肉质量和力量;导致疲劳,活动受限,最终失去独立性。背景:受损骨骼肌的有效恢复是由常驻卫星细胞的激活驱动的。同时,炎症反应清除细胞碎片并促进卫星细胞分化。然而,炎症过程也可以通过氧化应激损伤细胞成分来延迟恢复。如果暴露在适当的环境中,卫星细胞在整个生命过程中保持其再生潜力。因此,旨在增强卫星细胞活性和减少氧化应激的膳食补充剂具有改善骨骼肌的潜力 急性损伤后的康复。假设和方法:L-精氨酸可以作为一种抗氧化剂,以及在细胞培养中的卫星细胞激活的刺激剂。因此,我们提出了一种新的应用饮食L-精氨酸治疗,同时增加卫星细胞的活性和抑制体内炎症应激。本计画将利用细胞培养的初步资料,以活体动物模型探讨L-精氨酸对成人骨骼肌功能影响的机制。我们推测,急性肌毒素损伤后补充L-精氨酸将通过抑制炎症介质NF-κ B的活化和增强常驻卫星细胞的活化来增加肌肉质量的恢复。此外,这些影响将取决于一氧化氮的产生。意义:肌肉损伤后的身体康复是一项主要的医疗保健费用。更重要的是,随着年龄的增长,肌肉质量的损失加上受伤后肌肉无法完全恢复,导致身体虚弱和代谢疾病的风险增加。因此,该项目旨在 提高我们对肌肉再生机制的理解,并将基础科学数据转化为有效的膳食补充剂策略,以增强肌肉损伤的恢复。和收缩功能

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonardo Ferreira其他文献

Leonardo Ferreira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonardo Ferreira', 18)}}的其他基金

Systemic antioxidant treatment for cardiomyopathy, muscle weakness, and exercise intolerance in postmenopausal HFpEF
全身抗氧化治疗绝经后 HFpEF 患者的心肌病、肌无力和运动不耐受
  • 批准号:
    10593536
  • 财政年份:
    2022
  • 资助金额:
    $ 6.92万
  • 项目类别:
Reactive oxygen species and respiratory muscle dysfunction in heart failure
心力衰竭中的活性氧和呼吸肌功能障碍
  • 批准号:
    9005398
  • 财政年份:
    2016
  • 资助金额:
    $ 6.92万
  • 项目类别:
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure
心力衰竭中的活性氧和呼吸肌功能障碍
  • 批准号:
    10643945
  • 财政年份:
    2016
  • 资助金额:
    $ 6.92万
  • 项目类别:
Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure
心力衰竭中的活性氧和呼吸肌功能障碍
  • 批准号:
    10440819
  • 财政年份:
    2016
  • 资助金额:
    $ 6.92万
  • 项目类别:
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure
心力衰竭呼吸肌功能障碍的机制
  • 批准号:
    8331531
  • 财政年份:
    2011
  • 资助金额:
    $ 6.92万
  • 项目类别:
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure
心力衰竭呼吸肌功能障碍的机制
  • 批准号:
    8307125
  • 财政年份:
    2011
  • 资助金额:
    $ 6.92万
  • 项目类别:
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure
心力衰竭呼吸肌功能障碍的机制
  • 批准号:
    8523961
  • 财政年份:
    2011
  • 资助金额:
    $ 6.92万
  • 项目类别:
Mechanisms of Respiratory Muscle Dysfunction in Heart Failure
心力衰竭呼吸肌功能障碍的机制
  • 批准号:
    7771050
  • 财政年份:
    2010
  • 资助金额:
    $ 6.92万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 6.92万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了